Hydrocortisone 21-hemisuccinate (sodium salt) (Synonyms:氢化可的松琥珀酸钠;Hydrocortisone hemisuccinate sodium)
目录号 : KCM10835 CAS No. : 125-04-2 纯度 : ≥98%
Hydrocortisone 21-hemisuccinate is a water-soluble form of the endogenous hormone cortisol. It can bind to glucocorticoid receptors, initiating the transcription of anti-inflammatory and immunosuppressive mediators and inhibiting proinflammatory cytokine activity (IC = 6.7 µM for IL-6). It is commonly used to supplement media for long-term epithelial or endothelial cell cultures and to differentiate pluripotent stem cells.
规格 价格 是否有货 数量
100mg
In-stock
500mg
In-stock
1g
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Hydrocortisone 21-hemisuccinate (sodium salt) is an orally active physiological glucocorticoid. Hydrocortisone 21-hemisuccinate (sodium salt) inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone 21-hemisuccinate (sodium salt) can be used for the research of ulcerative colitis (UC).

体外研究

Hydrocortisone 21-hemisuccinate (sodium salt) inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells.

Hydrocortisone 21-hemisuccinate (sodium salt) (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures.

体内研究

Hydrocortisone 21-hemisuccinate (sodium salt) (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice.

 

Animal Model: Male Sprague-Dawley rats (200-220 g, 10-11 weeks) are induced colitis[1]
Dosage: 30 mg/kg
Administration: P.o. twice daily for 5 days
Result: Significantly decreased the disease activity index (DAI) scores and myeloperoxidase (MPO) activity compared to the 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) group. Increased the body weight.
 
分子式
C25H33O8.Na
分子量
484.51
CAS号
125-04-2
中文名称
氢化可的松琥珀酸钠
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

2-8°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO: 175 mg/mL (361.19 mM; Need ultrasonic)

H2O : 100 mg/mL (206.39 mM; Need ultrasonic)

配制储备液
                                           
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
                                                                                                                    
1 mM 2.0639 mL 10.3197 mL 20.6394 mL
5 mM 0.4128 mL 2.0639 mL 4.1279 mL
10 mM 0.2064 mL 1.0320 mL 2.0639 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度 mg/ml;

DMSO母液配制方法 mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。